Default: Trends in Biotechnology

ISSN: 0167-7799

Journal Home

Journal Guideline

Trends in Biotechnology Q1 Unclaimed

Elsevier Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Trends in Biotechnology is a journal indexed in SJR in Biotechnology and Bioengineering with an H index of 219. It has an SJR impact factor of 3,192 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,192.

Trends in Biotechnology focuses its scope in these topics and keywords: genomics, functional, smallest, worlds, guts, gene, coming, cloning, classes, cellsapplication, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

Trends in Biotechnology

3,192

SJR Impact factor

219

H Index

167

Total Docs (Last Year)

397

Total Docs (3 years)

11206

Total Refs

4561

Total Cites (3 years)

346

Citable Docs (3 years)

11,86

Cites/Doc (2 years)

67,10

Ref/Doc

Other journals with similar parameters


Nature Microbiology Q1
Nature Biomedical Engineering Q1
Nano Today Q1
PLoS Medicine Q1
BMC Biology Q1

Compare this journals

Aims and Scope


genomics, functional, smallest, worlds, guts, gene, coming, cloning, classes, cellsapplication, conjugatesinter, d, delivery, design, developments, direct, discoverythe, disease, cellderived, cell, cartilage, applications, applied, articular, assignment, baeyervilliger, biological, biologicsantibacterial, bioreactorsbiosensorsdirected, bioreactorsnanotechnologybased, biotechnological, brain, canadian,


Best articles

A broad perspective on protein engineering and complementary technologies

View more

A catalog with no hopes

View more

A glimpse at changes to come?

View more

Accessing new resources for drug discovery

View more

Advances in antisense efficacy and delivery

View more

Agricultural bug sequence

View more

Alzheimers vaccine?

View more

Ambiguities in the preclinical quality assessment of microparticulate vaccines

View more

Answering the question: 'Why did biocatalysis in organic media not take off in the 1930s?'

View more

Be still my beating heart

View more

Biocatalysis in organic chemistry (Part I): past and present

View more

Biocatalysis in organic chemistry (Part II): present and future

View more
SHOW MORE ARTICLES

Biocavity lasers for biomedicine

View more

Bioinformatics in the pre- and post-genomic eras

View more

Bioinformatics meets data mining: time to dance?

View more

Biotechnology in European society

View more

Biotechnology, inquiry, and public education

View more

Biotechnology, IPRs and Agriculture

View more

Breeding of Escherichia coli based on colour

View more

Bridging the gap with ORF ESTs

View more

Californian biotech power struggle

View more

Carbohydrate bioengineering

View more

Commercialization of gene therapy - the evolution of licensing and rights issues

View more

Conquering the proteome: complexity, cooperation and commerce

View more

Comments

No comments ... Be the first to comment!